Total Payments
$2,972
2024 Payments
$720.18
Companies
17
Transactions
178
Medicare Patients
4,001
Medicare Billing
$426,972
Payment Breakdown by Category
Food & Beverage$2,850 (95.9%)
Education$121.99 (4.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,850 | 176 | 95.9% |
| Education | $121.99 | 2 | 4.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $514.68 | 35 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $434.26 | 36 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $364.47 | 22 | $0 (2024) |
| Lilly USA, LLC | $354.61 | 21 | $0 (2024) |
| Janssen Biotech, Inc. | $249.40 | 13 | $0 (2024) |
| UCB, Inc. | $226.60 | 11 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $188.09 | 12 | $0 (2024) |
| GENZYME CORPORATION | $172.61 | 9 | $0 (2024) |
| Galderma Laboratories, L.P. | $163.75 | 2 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $122.44 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $720.18 | 42 | E.R. Squibb & Sons, L.L.C. ($131.68) |
| 2023 | $856.08 | 45 | E.R. Squibb & Sons, L.L.C. ($184.69) |
| 2022 | $565.65 | 34 | E.R. Squibb & Sons, L.L.C. ($117.89) |
| 2021 | $349.99 | 26 | AbbVie Inc. ($156.13) |
| 2020 | $192.89 | 13 | LEO Pharma Inc. ($43.35) |
| 2019 | $151.78 | 12 | Novartis Pharmaceuticals Corporation ($53.80) |
| 2018 | $135.61 | 6 | Janssen Biotech, Inc. ($123.10) |
All Payment Transactions
178 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: ONCOLOGY | ||||||
| 12/18/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: Immunology | ||||||
| 11/26/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Dermatology | ||||||
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $20.59 | General |
| Category: Immunology | ||||||
| 10/22/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: Immunology | ||||||
| 10/08/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Dermatology | ||||||
| 09/17/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: ANTIBIOTIC | ||||||
| 09/12/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: Dermatology | ||||||
| 09/10/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $20.02 | General |
| Category: Immunology | ||||||
| 09/10/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $2.45 | General |
| Category: Immunology | ||||||
| 09/06/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $26.35 | General |
| Category: Immunology | ||||||
| 08/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: Immunology | ||||||
| 08/13/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: IMMUNOLOGY | ||||||
| 08/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: IMMUNOLOGY | ||||||
| 07/30/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Immunology | ||||||
| 07/23/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $15.98 | General |
| Category: Immunology | ||||||
| 07/23/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $2.53 | General |
| Category: Immunology | ||||||
| 07/11/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $9.80 | General |
| Category: Immunology | ||||||
| 06/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $29.16 | General |
| Category: IMMUNOLOGY | ||||||
| 06/19/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: Dermatology | ||||||
| 06/13/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Dermatology | ||||||
| 05/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: IMMUNOLOGY | ||||||
| 05/15/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $19.02 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,380 | 2,149 | $887,046 | $173,401 |
| 2022 | 15 | 1,114 | 1,867 | $430,896 | $103,491 |
| 2021 | 16 | 921 | 1,603 | $361,484 | $93,655 |
| 2020 | 11 | 586 | 1,138 | $353,024 | $56,426 |
Total Patients
4,001
Total Services
6,757
Medicare Billing
$426,972
Procedure Codes
62
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 116 | 128 | $336,239 | $49,608 | 14.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 272 | 402 | $86,712 | $22,973 | 26.5% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 36 | 50 | $76,639 | $15,496 | 20.2% |
| 15260 | Full thickness skin graft to nose, ears, eyelids, or lips, 20.0 sq cm or less | Office | 2023 | 17 | 17 | $62,507 | $12,681 | 20.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 96 | 130 | $39,748 | $11,486 | 28.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 140 | 151 | $36,959 | $10,441 | 28.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 208 | 263 | $42,299 | $10,317 | 24.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 144 | 144 | $38,227 | $9,186 | 24.0% |
| 14041 | Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.1-30.0 sq cm | Office | 2023 | 12 | 12 | $38,148 | $8,159 | 21.4% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 23 | 23 | $43,618 | $4,253 | 9.8% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 21 | 23 | $19,481 | $3,743 | 19.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 161 | 641 | $10,423 | $3,112 | 29.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 35 | 35 | $13,851 | $3,071 | 22.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 14 | 28 | $7,665 | $2,191 | 28.6% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2023 | 15 | 15 | $16,726 | $2,095 | 12.5% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 13 | 18 | $7,711 | $1,722 | 22.3% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 30 | 40 | $4,840 | $1,483 | 30.6% |
| 69100 | Biopsy of ear | Office | 2023 | 13 | 14 | $3,234 | $834.67 | 25.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 14 | 15 | $2,019 | $550.16 | 27.2% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2022 | 57 | 68 | $109,956 | $26,027 | 23.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 209 | 300 | $65,400 | $16,011 | 24.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 132 | 157 | $38,936 | $10,216 | 26.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 154 | 154 | $41,118 | $9,932 | 24.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 78 | 115 | $35,535 | $9,542 | 26.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 181 | 235 | $37,835 | $8,446 | 22.3% |
About Dr. Burt Steffes, MD
Dr. Burt Steffes, MD is a Dermatology healthcare provider based in Fond Du Lac, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/25/2007. The National Provider Identifier (NPI) number assigned to this provider is 1548449614.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Burt Steffes, MD has received a total of $2,972 in payments from pharmaceutical and medical device companies, with $720.18 received in 2024. These payments were reported across 178 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($2,850).
As a Medicare-enrolled provider, Steffes has provided services to 4,001 Medicare beneficiaries, totaling 6,757 services with total Medicare billing of $426,972. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Fond Du Lac, WI
- Active Since 10/25/2007
- Last Updated 01/28/2020
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1548449614
Products in Payments
- SKYRIZI (Biological) $396.21
- Sotyktu (Drug) $372.89
- TALTZ (Drug) $340.05
- COSENTYX (Biological) $210.23
- DUPIXENT (Biological) $200.93
- COSENTYX (Drug) $154.24
- Cimzia (Drug) $150.46
- ILUMYA (Biological) $144.27
- Tremfya (Drug) $134.18
- TREMFYA (Drug) $97.34
- LIBTAYO (Biological) $80.73
- RINVOQ (Biological) $79.66
- Bimzelx (Biological) $76.14
- SPEVIGO (Drug) $56.76
- Ilumya (Biological) $31.24
- HUMIRA (Biological) $24.26
- NUZYRA (Drug) $18.13
- REMICADE (Biological) $17.88
- EPSOLAY (Drug) $16.84
- Puraply (Medical Supply) $15.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.